A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

CHARLOTTESVILLE, Va. — A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

The AACE released the 2026 update to its algorithm for the management of adults with type 2 diabetes. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and ...

Insulet enrolled the first participant in a study of its fully closed-loop automated insulin delivery system for type 2 ...

A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...

In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...